{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:18:05Z","timestamp":1763705885993,"version":"3.37.3"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council\u00a0of\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Approximately 80% - 90% of individuals infected with latent<jats:italic>Mycobacterium tuberculosis (Mtb)<\/jats:italic>remain protected throughout their life-span. The release of unique, latent-phase antigens are known to have a protective role in the immune response against<jats:italic>Mtb<\/jats:italic>. Although the BCG vaccine has been administered for nine decades to provide immunity against<jats:italic>Mtb<\/jats:italic>, the number of TB cases continues to rise, thereby raising doubts on BCG vaccine efficacy. The shortcomings of BCG have been associated with inadequate processing and presentation of its antigens, an inability to optimally activate T cells against<jats:italic>Mtb<\/jats:italic>, and generation of regulatory T cells. Furthermore, BCG vaccination lacks the ability to eliminate latent<jats:italic>Mtb<\/jats:italic>infection. With these facts in mind, we selected six immunodominant CD4 and CD8 T cell epitopes of<jats:italic>Mtb<\/jats:italic>expressed during latent, acute, and chronic stages of infection and engineered a multi-epitope-based DNA vaccine (C6).<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>BALB\/c mice vaccinated with the C6 construct along with a BCG vaccine exhibited an expansion of both CD4 and CD8 T cell memory populations and augmented IFN-\u03b3 and TNF-\u03b1 cytokine release. Furthermore, enhancement of dendritic cell and macrophage activation was noted. Consequently, illustrating the elicitation of immunity that helps in the protection against<jats:italic>Mtb<\/jats:italic>infection; which was evident by a significant reduction in the<jats:italic>Mtb<\/jats:italic>burden in the lungs and spleen of C6\u2009+\u2009BCG administered animals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall, the results suggest that a C6\u2009+\u2009BCG vaccination approach may serve as an effective vaccination strategy in future attempts to control TB.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-020-05372-1","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T15:06:15Z","timestamp":1600355175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette\u2013Gu\u00e9rin (BCG) against Mycobacterium tuberculosis"],"prefix":"10.1186","volume":"20","author":[{"given":"Sudeep Kumar","family":"Maurya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Aqdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepjyoti Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajid","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6786-3239","authenticated-orcid":false,"given":"Javed Naim","family":"Agrewala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"5372_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fimmu.2017.00556","volume":"8","author":"PJ Cardona","year":"2017","unstructured":"Cardona PJ. What we have learned and what we have missed in tuberculosis pathophysiology for a new vaccine design: searching for the \u201cpink swan\u201d. Front Immunol. 2017;8:556.","journal-title":"Front Immunol"},{"key":"5372_CR2","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3389\/fimmu.2017.01755","volume":"8","author":"UE Schaible","year":"2017","unstructured":"Schaible UE, Linnemann L, Redinger N, Patin EC, Dallenga T. Strategies to improve vaccine efficacy against tuberculosis by targeting innate immunity. Front Immunol. 2017;8:1755.","journal-title":"Front Immunol"},{"issue":"4","key":"5372_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","volume":"33","author":"SH Kaufmann","year":"2010","unstructured":"Kaufmann SH. Future vaccination strategies against tuberculosis: thinking outside the box. Immunity. 2010;33(4):567\u201377.","journal-title":"Immunity"},{"issue":"5980","key":"5372_CR4","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1126\/science.1184784","volume":"328","author":"DG Russell","year":"2010","unstructured":"Russell DG, Barry CE 3rd, Flynn JL. Tuberculosis: what we don't know can, and does, hurt us. Science. 2010;328(5980):852\u20136.","journal-title":"Science"},{"issue":"3","key":"5372_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1046\/j.1365-2958.2002.03237.x","volume":"46","author":"AS Pym","year":"2002","unstructured":"Pym AS, Brodin P, Brosch R, Huerre M, Cole ST. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol. 2002;46(3):709\u201317.","journal-title":"Mol Microbiol"},{"issue":"11","key":"5372_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002378","volume":"7","author":"S Chatterjee","year":"2011","unstructured":"Chatterjee S, Dwivedi VP, Singh Y, Siddiqui I, Sharma P, Van Kaer L, Chattopadhyay D, Das G. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner. PLoS Pathog. 2011;7(11):e1002378.","journal-title":"PLoS Pathog"},{"key":"5372_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijid.2016.10.018","volume":"56","author":"SH Kaufmann","year":"2017","unstructured":"Kaufmann SH, Weiner J, von Reyn CF. Novel approaches to tuberculosis vaccine development. Int J Infect Dis. 2017;56:263\u20137.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"5372_CR8","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/infdis\/jir548","volume":"204","author":"U Gowthaman","year":"2011","unstructured":"Gowthaman U, Singh V, Zeng W, Jain S, Siddiqui KF, Chodisetti SB, Gurram RK, Parihar P, Gupta P, Gupta UD, et al. Promiscuous peptide of 16 kDa antigen linked to Pam2Cys protects against Mycobacterium tuberculosis by evoking enduring memory T-cell response. J Infect Dis. 2011;204(9):1328\u201338.","journal-title":"J Infect Dis"},{"issue":"1","key":"5372_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12967-018-1653-x","volume":"16","author":"PK Rai","year":"2018","unstructured":"Rai PK, Chodisetti SB, Maurya SK, Nadeem S, Zeng W, Janmeja AK, Jackson DC, Agrewala JN. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis. J Transl Med. 2018;16(1):279.","journal-title":"J Transl Med"},{"issue":"10","key":"5372_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrg2432","volume":"9","author":"MA Kutzler","year":"2008","unstructured":"Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat Rev Genet. 2008;9(10):776\u201388.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"5372_CR11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1046\/j.1365-2249.1998.00724.x","volume":"114","author":"JN Agrewala","year":"1998","unstructured":"Agrewala JN, Wilkinson RJ. Differential regulation of Th1 and Th2 cells by p91-110 and p21-40 peptides of the 16-kD alpha-crystallin antigen of Mycobacterium tuberculosis. Clin Exp Immunol. 1998;114(3):392\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"5372_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1365-2567.2009.03201.x","volume":"129","author":"R Axelsson-Robertson","year":"2010","unstructured":"Axelsson-Robertson R, Weichold F, Sizemore D, Wulf M, Skeiky YA, Sadoff J, Maeurer MJ. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses. Immunology. 2010;129(4):496\u2013505.","journal-title":"Immunology"},{"issue":"8","key":"5372_CR13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.molimm.2011.01.006","volume":"48","author":"R Kovjazin","year":"2011","unstructured":"Kovjazin R, Volovitz I, Daon Y, Vider-Shalit T, Azran R, Tsaban L, Carmon L, Louzoun Y. Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: implications for vaccine development. Mol Immunol. 2011;48(8):1009\u201318.","journal-title":"Mol Immunol"},{"issue":"3","key":"5372_CR14","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.4049\/jimmunol.173.3.1966","volume":"173","author":"H Shams","year":"2004","unstructured":"Shams H, Klucar P, Weis SE, Lalvani A, Moonan PK, Safi H, Wizel B, Ewer K, Nepom GT, Lewinsohn DM, et al. Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles. J Immunol. 2004;173(3):1966\u201377.","journal-title":"J Immunol"},{"issue":"11","key":"5372_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050300","volume":"7","author":"J Song","year":"2012","unstructured":"Song J, Tan H, Perry AJ, Akutsu T, Webb GI, Whisstock JC, Pike RN. PROSPER: an integrated feature-based tool for predicting protease substrate cleavage sites. PLoS One. 2012;7(11):e50300.","journal-title":"PLoS One"},{"issue":"32","key":"5372_CR16","doi-asserted-by":"crossref","first-page":"19996","DOI":"10.1016\/S0021-9258(17)45473-1","volume":"265","author":"J Hall","year":"1990","unstructured":"Hall J, Hazlewood GP, Surani MA, Hirst BH, Gilbert HJ. Eukaryotic and prokaryotic signal peptides direct secretion of a bacterial endoglucanase by mammalian cells. J Biol Chem. 1990;265(32):19996\u20139.","journal-title":"J Biol Chem"},{"key":"5372_CR17","first-page":"59","volume":"2017","author":"H Nielsen","year":"1611","unstructured":"Nielsen H. Predicting secretory proteins with SignalP. Methods Mol Biol. 1611;2017:59\u201373.","journal-title":"Methods Mol Biol"},{"key":"5372_CR18","doi-asserted-by":"publisher","first-page":"854507","DOI":"10.1155\/2015\/854507","volume":"2015","author":"IV Lyadova","year":"2015","unstructured":"Lyadova IV, Panteleev AV. Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers. Mediat Inflamm. 2015;2015:854507.","journal-title":"Mediat Inflamm"},{"issue":"1","key":"5372_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1600-065X.2010.00997.x","volume":"240","author":"DA Lewinsohn","year":"2011","unstructured":"Lewinsohn DA, Gold MC, Lewinsohn DM. Views of immunology: effector T cells. Immunol Rev. 2011;240(1):25\u201339.","journal-title":"Immunol Rev"},{"issue":"7","key":"5372_CR20","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4161\/viru.22586","volume":"3","author":"A Mihret","year":"2012","unstructured":"Mihret A. The role of dendritic cells in Mycobacterium tuberculosis infection. Virulence. 2012;3(7):654\u20139.","journal-title":"Virulence"},{"issue":"5","key":"5372_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00281-013-0388-2","volume":"35","author":"E Guirado","year":"2013","unstructured":"Guirado E, Schlesinger LS, Kaplan G. Macrophages in tuberculosis: friend or foe. Semin Immunopathol. 2013;35(5):563\u201383.","journal-title":"Semin Immunopathol"},{"key":"5372_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3389\/fimmu.2017.00624","volume":"8","author":"M Amir","year":"2017","unstructured":"Amir M, Aqdas M, Nadeem S, Siddiqui KF, Khan N, Sheikh JA, Agrewala JN. Diametric role of the latency-associated protein Acr1 of Mycobacterium tuberculosis in modulating the functionality of pre- and post-maturational stages of dendritic cells. Front Immunol. 2017;8:624.","journal-title":"Front Immunol"},{"key":"5372_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep. 2014;6:13.","journal-title":"F1000prime Rep"},{"key":"5372_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1479-5876-8-4","volume":"8","author":"P Jin","year":"2010","unstructured":"Jin P, Han TH, Ren J, Saunders S, Wang E, Marincola FM, Stroncek DF. Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies. J Transl Med. 2010;8:4.","journal-title":"J Transl Med"},{"issue":"1\u20132","key":"5372_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.imlet.2004.05.003","volume":"94","author":"J Pan","year":"2004","unstructured":"Pan J, Zhang M, Wang J, Wang Q, Xia D, Sun W, Zhang L, Yu H, Liu Y, Cao X. Interferon-gamma is an autocrine mediator for dendritic cell maturation. Immunol Lett. 2004;94(1\u20132):141\u201351.","journal-title":"Immunol Lett"},{"issue":"3","key":"5372_CR26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2006-05-015354","volume":"109","author":"D Vremec","year":"2007","unstructured":"Vremec D, O'Keeffe M, Hochrein H, Fuchsberger M, Caminschi I, Lahoud M, Shortman K. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. Blood. 2007;109(3):1165\u201373.","journal-title":"Blood"},{"issue":"6","key":"5372_CR27","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1128\/IAI.01826-06","volume":"75","author":"SL Young","year":"2007","unstructured":"Young SL, Slobbe L, Wilson R, Buddle BM, de Lisle GW, Buchan GS. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination. Infect Immun. 2007;75(6):2833\u201340.","journal-title":"Infect Immun"},{"key":"5372_CR28","doi-asserted-by":"publisher","first-page":"793292","DOI":"10.1155\/2015\/793292","volume":"2015","author":"LV Sakhno","year":"2015","unstructured":"Sakhno LV, Shevela EY, Tikhonova MA, Nikonov SD, Ostanin AA, Chernykh ER. Impairments of antigen-presenting cells in pulmonary tuberculosis. J Immunol Res. 2015;2015:793292.","journal-title":"J Immunol Res"},{"key":"5372_CR29","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3389\/fimmu.2017.01864","volume":"8","author":"R Lang","year":"2017","unstructured":"Lang R, Schick J. Review: impact of Helminth infection on Antimycobacterial immunity-a focus on the macrophage. Front Immunol. 2017;8:1864.","journal-title":"Front Immunol"},{"issue":"1","key":"5372_CR30","first-page":"53","volume":"8","author":"S Luca","year":"2013","unstructured":"Luca S, Mihaescu T. History of BCG vaccine. Maedica. 2013;8(1):53\u20138.","journal-title":"Maedica"},{"issue":"4","key":"5372_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018773","volume":"6","author":"B Dey","year":"2011","unstructured":"Dey B, Jain R, Khera A, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK. Latency antigen alpha-crystallin based vaccination imparts a robust protection against TB by modulating the dynamics of pulmonary cytokines. PLoS One. 2011;6(4):e18773.","journal-title":"PLoS One"},{"issue":"16","key":"5372_CR32","doi-asserted-by":"publisher","first-page":"9578","DOI":"10.1073\/pnas.95.16.9578","volume":"95","author":"Y Yuan","year":"1998","unstructured":"Yuan Y, Crane DD, Simpson RM, Zhu YQ, Hickey MJ, Sherman DR, Barry CE 3rd. The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci U S A. 1998;95(16):9578\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5372_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2567.2009.03196.x","volume":"130","author":"N Bashir","year":"2010","unstructured":"Bashir N, Kounsar F, Mukhopadhyay S, Hasnain SE. Mycobacterium tuberculosis conserved hypothetical protein rRv2626c modulates macrophage effector functions. Immunology. 2010;130(1):34\u201345.","journal-title":"Immunology"},{"issue":"1","key":"5372_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/21505594.2015.1102832","volume":"7","author":"L Danelishvili","year":"2016","unstructured":"Danelishvili L, Everman J, Bermudez LE. Mycobacterium tuberculosis PPE68 and Rv2626c genes contribute to the host cell necrosis and bacterial escape from macrophages. Virulence. 2016;7(1):23\u201332.","journal-title":"Virulence"},{"issue":"4","key":"5372_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061135","volume":"8","author":"G Feng","year":"2013","unstructured":"Feng G, Jiang Q, Xia M, Lu Y, Qiu W, Zhao D, Lu L, Peng G, Wang Y. Enhanced immune response and protective effects of nano-chitosan-based DNA vaccine encoding T cell epitopes of Esat-6 and FL against Mycobacterium tuberculosis infection. PLoS One. 2013;8(4):e61135.","journal-title":"PLoS One"},{"issue":"3","key":"5372_CR36","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4269\/ajtmh.17-0416","volume":"98","author":"JR Danko","year":"2018","unstructured":"Danko JR, Kochel T, Teneza-Mora N, Luke TC, Raviprakash K, Sun P, Simmons M, Moon JE, De La Barrera R, Martinez LJ, et al. Safety and immunogenicity of a tetravalent dengue DNA vaccine administered with a cationic lipid-based adjuvant in a phase 1 clinical trial. Am J Trop Med Hyg. 2018;98(3):849\u201356.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"5372_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5455\/vetworld.2013.228-232","volume":"6","author":"K Kumaragurubaran","year":"2013","unstructured":"Kumaragurubaran K, Kaliaperumal K. DNA vaccine: the miniature miracle. Vet World. 2013;6(4):228\u201332.","journal-title":"Vet World"},{"key":"5372_CR38","doi-asserted-by":"crossref","unstructured":"Li SS, Kochar NK, Elizaga M, Hay CM, Wilson GJ, Cohen KW, De Rosa SC, Xu R, Ota-Setlik A, Morris D, et al. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8(+) T-Cell Responses by Interleukin-12 Plasmid DNA. Clin Vaccine Immunol. 2017;24(11):e00263-17.","DOI":"10.1128\/CVI.00263-17"},{"key":"5372_CR39","unstructured":"Li X, Pushko P, Tretyakova I. Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus. J Vaccines Vaccination. 2015;6(3)."},{"issue":"8","key":"5372_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrd.2016.159","volume":"15","author":"C Morrison","year":"2016","unstructured":"Morrison C. DNA vaccines against Zika virus speed into clinical trials. Nat Rev Drug Discov. 2016;15(8):521\u20132.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"5372_CR41","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1128\/IAI.68.6.3097-3102.2000","volume":"68","author":"G Delogu","year":"2000","unstructured":"Delogu G, Howard A, Collins FM, Morris SL. DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity. Infect Immun. 2000;68(6):3097\u2013102.","journal-title":"Infect Immun"},{"issue":"8","key":"5372_CR42","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm0896-893","volume":"2","author":"K Huygen","year":"1996","unstructured":"Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, DeWitt CM, Orme IM, Baldwin S, D'Souza C, et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med. 1996;2(8):893\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"5372_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.dci.2015.09.001","volume":"54","author":"KE Oksanen","year":"2016","unstructured":"Oksanen KE, Myllymaki H, Ahava MJ, Makinen L, Parikka M, Ramet M. DNA vaccination boosts Bacillus Calmette-Guerin protection against mycobacterial infection in zebrafish. Dev Comp Immunol. 2016;54(1):89\u201396.","journal-title":"Dev Comp Immunol"},{"issue":"12","key":"5372_CR44","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","volume":"172","author":"YA Skeiky","year":"2004","unstructured":"Skeiky YA, Alderson MR, Ovendale PJ, Guderian JA, Brandt L, Dillon DC, Campos-Neto A, Lobet Y, Dalemans W, Orme IM, et al. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J Immunol. 2004;172(12):7618\u201328.","journal-title":"J Immunol"},{"issue":"4","key":"5372_CR45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1089\/dna.2011.1309","volume":"31","author":"Q Wang","year":"2012","unstructured":"Wang Q, Lei C, Wan H, Liu Q. Improved cellular immune response elicited by a ubiquitin-fused DNA vaccine against Mycobacterium tuberculosis. DNA Cell Biol. 2012;31(4):489\u201395.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"5372_CR46","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/IAI.74.1.557-565.2006","volume":"74","author":"TM Wozniak","year":"2006","unstructured":"Wozniak TM, Ryan AA, Triccas JA, Britton WJ. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infect Immun. 2006;74(1):557\u201365.","journal-title":"Infect Immun"},{"issue":"6","key":"5372_CR47","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1172\/JCI64704","volume":"123","author":"J Zhou","year":"2013","unstructured":"Zhou J, Cheung AK, Tan Z, Wang H, Yu W, Du Y, Kang Y, Lu X, Liu L, Yuen KY, et al. PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice. J Clin Invest. 2013;123(6):2629\u201342.","journal-title":"J Clin Invest"},{"issue":"1","key":"5372_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2567.2010.03260.x","volume":"130","author":"MK MacLeod","year":"2010","unstructured":"MacLeod MK, Kappler JW, Marrack P. Memory CD4 T cells: generation, reactivation and re-assignment. Immunology. 2010;130(1):10\u20135.","journal-title":"Immunology"},{"key":"5372_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","volume":"27","author":"AM Cooper","year":"2009","unstructured":"Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol. 2009;27:393\u2013422.","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"5372_CR50","doi-asserted-by":"publisher","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","volume":"190","author":"T Lindenstrom","year":"2013","unstructured":"Lindenstrom T, Knudsen NP, Agger EM, Andersen P. Control of chronic Mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells. J Immunol. 2013;190(12):6311\u20139.","journal-title":"J Immunol"},{"issue":"11","key":"5372_CR51","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.1128\/IAI.73.11.7759-7764.2005","volume":"73","author":"A Kipnis","year":"2005","unstructured":"Kipnis A, Irwin S, Izzo AA, Basaraba RJ, Orme IM. Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 ligand (hi) population. Infect Immun. 2005;73(11):7759\u201364.","journal-title":"Infect Immun"},{"issue":"1","key":"5372_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4049\/jimmunol.170.1.28","volume":"170","author":"RL Hengel","year":"2003","unstructured":"Hengel RL, Thaker V, Pavlick MV, Metcalf JA, Dennis G Jr, Yang J, Lempicki RA, Sereti I, Lane HC. Cutting edge: L-selectin (CD62L) expression distinguishes small resting memory CD4+ T cells that preferentially respond to recall antigen. J Immunol. 2003;170(1):28\u201332.","journal-title":"J Immunol"},{"issue":"10","key":"5372_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141577","volume":"10","author":"SB Cha","year":"2015","unstructured":"Cha SB, Kim WS, Kim JS, Kim H, Kwon KW, Han SJ, Eum SY, Cho SN, Shin SJ. Repeated aerosolized-boosting with gamma-irradiated Mycobacterium bovis BCG confers improved pulmonary protection against the Hypervirulent Mycobacterium tuberculosis strain HN878 in mice. PLoS One. 2015;10(10):e0141577.","journal-title":"PLoS One"},{"issue":"4","key":"5372_CR54","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1128\/CVI.00368-09","volume":"17","author":"MI Henao-Tamayo","year":"2010","unstructured":"Henao-Tamayo MI, Ordway DJ, Irwin SM, Shang S, Shanley C, Orme IM. Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin Vaccine Immunol. 2010;17(4):618\u201325.","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"5372_CR55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12026-007-8004-y","volume":"40","author":"KK McKinstry","year":"2008","unstructured":"McKinstry KK, Strutt TM, Swain SL. The effector to memory transition of CD4 T cells. Immunol Res. 2008;40(2):114\u201327.","journal-title":"Immunol Res"},{"key":"5372_CR56","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","volume":"101","author":"S Sharpe","year":"2016","unstructured":"Sharpe S, White A, Sarfas C, Sibley L, Gleeson F, McIntyre A, Basaraba R, Clark S, Hall G, Rayner E, et al. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations. Tuberculosis. 2016;101:174\u201390.","journal-title":"Tuberculosis"},{"issue":"6","key":"5372_CR57","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","volume":"178","author":"AM Cooper","year":"1993","unstructured":"Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993;178(6):2243\u20137.","journal-title":"J Exp Med"},{"issue":"6","key":"5372_CR58","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","volume":"178","author":"JL Flynn","year":"1993","unstructured":"Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993;178(6):2249\u201354.","journal-title":"J Exp Med"},{"issue":"6","key":"5372_CR59","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","volume":"2","author":"JL Flynn","year":"1995","unstructured":"Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995;2(6):561\u201372.","journal-title":"Immunity"},{"issue":"6","key":"5372_CR60","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","volume":"170","author":"DF Fiorentino","year":"1989","unstructured":"Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170(6):2081\u201395.","journal-title":"J Exp Med"},{"key":"5372_CR61","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683\u2013765.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"5372_CR62","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1365-2567.2007.02575.x","volume":"121","author":"J Madura Larsen","year":"2007","unstructured":"Madura Larsen J, Benn CS, Fillie Y, van der Kleij D, Aaby P, Yazdanbakhsh M. BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology. 2007;121(2):276\u201382.","journal-title":"Immunology"},{"issue":"3","key":"5372_CR63","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1165\/ajrcmb.11.3.8086170","volume":"11","author":"JM van Haarst","year":"1994","unstructured":"van Haarst JM, Hoogsteden HC, de Wit HJ, Verhoeven GT, Havenith CE, Drexhage HA. Dendritic cells and their precursors isolated from human bronchoalveolar lavage: immunocytologic and functional properties. Am J Respir Cell Mol Biol. 1994;11(3):344\u201350.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"5372_CR64","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.4049\/jimmunol.166.12.7033","volume":"166","author":"E Giacomini","year":"2001","unstructured":"Giacomini E, Iona E, Ferroni L, Miettinen M, Fattorini L, Orefici G, Julkunen I, Coccia EM. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol. 2001;166(12):7033\u201341.","journal-title":"J Immunol"},{"issue":"7","key":"5372_CR65","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.addr.2007.12.004","volume":"60","author":"Y Kumagai","year":"2008","unstructured":"Kumagai Y, Takeuchi O, Akira S. TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev. 2008;60(7):795\u2013804.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"5372_CR66","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/j.1365-2567.1999.00888.x","volume":"98","author":"K Vandenborre","year":"1999","unstructured":"Vandenborre K, Van Gool SW, Kasran A, Ceuppens JL, Boogaerts MA, Vandenberghe P. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation. Immunology. 1999;98(3):413\u201321.","journal-title":"Immunology"},{"issue":"8","key":"5372_CR67","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.4049\/jimmunol.157.8.3577","volume":"157","author":"L Lu","year":"1996","unstructured":"Lu L, Bonham CA, Chambers FG, Watkins SC, Hoffman RA, Simmons RL, Thomson AW. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol. 1996;157(8):3577\u201386.","journal-title":"J Immunol"},{"issue":"3","key":"5372_CR68","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/mi.2011.7","volume":"4","author":"PS Redford","year":"2011","unstructured":"Redford PS, Murray PJ, O'Garra A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 2011;4(3):261\u201370.","journal-title":"Mucosal Immunol"},{"key":"5372_CR69","first-page":"411","volume":"3","author":"S Ehlers","year":"2012","unstructured":"Ehlers S, Schaible UE. The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front Immunol. 2012;3:411.","journal-title":"Front Immunol"},{"key":"5372_CR70","doi-asserted-by":"publisher","first-page":"8132741","DOI":"10.1155\/2016\/8132741","volume":"2016","author":"M Gupta","year":"2016","unstructured":"Gupta M, Lobo FD, Adiga DS, Gupta A. A histomorphological pattern analysis of pulmonary tuberculosis in lung autopsy and surgically resected specimens. Pathol Res Int. 2016;2016:8132741.","journal-title":"Pathol Res Int"},{"issue":"1","key":"5372_CR71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12967-017-1301-x","volume":"15","author":"PK Rai","year":"2017","unstructured":"Rai PK, Chodisetti SB, Zeng W, Nadeem S, Maurya SK, Pahari S, Janmeja AK, Jackson DC, Agrewala JN. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity. J Transl Med. 2017;15(1):201.","journal-title":"J Transl Med"},{"issue":"2","key":"5372_CR72","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ab.2012.02.015","volume":"424","author":"R Ma","year":"2012","unstructured":"Ma R, Zhao J, Du HC, Tian S, Li LW. Removing endotoxin from plasmid samples by triton X-114 isothermal extraction. Anal Biochem. 2012;424(2):124\u20136.","journal-title":"Anal Biochem"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05372-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05372-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05372-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T13:14:49Z","timestamp":1696684489000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05372-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5372"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05372-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"28 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The uses of animals were permitted by the Institutional Animal Ethics Committees (IAEC) of IMTECH, Chandigarh. The experiments were accomplished conferring to the National Regulatory Guideline issued by Committee for the Purpose of Control and Supervision of Experiments on Animals (No. 55\/1999\/CPCSEA), Ministry of Environment and Forest, Govt. of India.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors give consent for publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"677"}}